International audienceBACKGROUND: The value of transient elastography for the non-invasive diagnosis of alcohol-related liver fibrosis is subject to debate. We did an individual patient data (IPD) meta-analysis to determine specific diagnostic cutoff values for liver stiffness in alcohol-related fibrosis, and to assess the effect of aminotransferase concentrations, bilirubin concentrations, and presence of asymptomatic and non-severe alcoholic hepatitis on liver stiffness.METHODS: We searched for studies that included patients with alcohol-related liver disease, liver biopsy, and transient elastography, and with a statistical method for determining the diagnostic cutoffs for alcohol-induced liver fibrosis on the basis of the FibroScan resul...
Background and Aims. Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) have...
Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at risk of d...
BACKGROUND & AIMS: Liver biopsy is invasive and associated with complications, sampling errors, and ...
International audienceBACKGROUND: The value of transient elastography for the non-invasive diagnosis...
The value of transient elastography for the non-invasive diagnosis of alcohol-related liver fibrosis...
15noINTRODUCTION: Alcohol-related liver disease (ALD) was estimated to have a prevalence of 2% among...
BACKGROUND/GOALS: Consensus is lacking whether cut-off values for different fibrosis stages using tr...
International audienceBACKGROUND AND AIMS: Liver stiffness measurement by transient elastography (TE...
Background The progression of hepatic fibrosis into cirrhosis is a main prognostic factor for surviv...
International audienceAIM: To determine the evolution of transient elastography (TE) in patients wit...
Objective: This study aimed to assess the accuracy of staging liver fibrosis in Non-Alcoholic Fatty ...
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatt...
Alcohol is globally the leading risk factor for cirrhosis and is subsumed under the term alcohol-rel...
Background: Transient elastography (TE) is a new modality for the diagnosis of liver fibrosis caused...
[Background & Aims] Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAF...
Background and Aims. Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) have...
Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at risk of d...
BACKGROUND & AIMS: Liver biopsy is invasive and associated with complications, sampling errors, and ...
International audienceBACKGROUND: The value of transient elastography for the non-invasive diagnosis...
The value of transient elastography for the non-invasive diagnosis of alcohol-related liver fibrosis...
15noINTRODUCTION: Alcohol-related liver disease (ALD) was estimated to have a prevalence of 2% among...
BACKGROUND/GOALS: Consensus is lacking whether cut-off values for different fibrosis stages using tr...
International audienceBACKGROUND AND AIMS: Liver stiffness measurement by transient elastography (TE...
Background The progression of hepatic fibrosis into cirrhosis is a main prognostic factor for surviv...
International audienceAIM: To determine the evolution of transient elastography (TE) in patients wit...
Objective: This study aimed to assess the accuracy of staging liver fibrosis in Non-Alcoholic Fatty ...
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatt...
Alcohol is globally the leading risk factor for cirrhosis and is subsumed under the term alcohol-rel...
Background: Transient elastography (TE) is a new modality for the diagnosis of liver fibrosis caused...
[Background & Aims] Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAF...
Background and Aims. Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) have...
Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at risk of d...
BACKGROUND & AIMS: Liver biopsy is invasive and associated with complications, sampling errors, and ...